Evidence map›Paper›PMID 39486023›Full record

ArticleJMIR formative research2024

Understanding Users' Engagement in a Provider-Created Mobile App for Training to Advance Hepatitis C Care: Knowledge Assessment Survey Study.

Maximilian Wegener, Katarzyna Sims, Ralph Brooks, Lisa Nichols, Robert Sideleau, Sharen McKay, Merceditas Villanueva

Abstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maximilian Wegener *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0000-0001-6765-594X
Katarzyna Sims *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0009-0000-6080-4324
Ralph Brooks *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0000-0003-2462-0776
Lisa Nichols *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0009-0002-9463-0945
Robert Sideleau *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.
Sharen McKay *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0000-0002-2640-2759
Merceditas Villanueva *Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States.ORCID 0000-0003-1022-7746

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundThe World Health Organization and the Centers for Disease Control and Prevention have set ambitious hepatitis C virus (HCV) elimination targets for 2030. Current estimates show that the United States is not on pace to meet elimination targets due to multiple patient, clinic, institutional, and societal level barriers that contribute to HCV testing and treatment gaps. Among these barriers are unawareness of testing and treatment needs, misinformation concerning adverse treatment reactions, need for substance use sobriety, and treatment efficacy. Strategies to improve viral hepatitis education are needed.

objectiveWe aim to provide a high-quality HCV educational app for patients and health care workers, particularly nonprescriber staff. The app was vetted by health care providers and designed to guide users through the HCV testing and treatment stages in a self-exploratory way to promote engagement and knowledge retention. The app is comprised of five learning modules: (1) Testing for Hep C (hepatitis C), (2) Tests for Hep C Positive Patients, (3) Treatments Available to You, (4) What to Expect During Treatment, and (5) What to Expect After Treatment.

methodsAn HCV knowledge assessment survey was administered to providers and patients at the Yale School of Medicine and 11 Connecticut HIV clinics as part of a grant-funded activity. The survey findings and pilot testing feedback guided the app's design and content development. Data on app usage from November 2019 to November 2022 were analyzed, focusing on user demographics, engagement metrics, and module usage patterns.

resultsThere were 561 app users; 216 (38.5%) accessed the training modules of which 151 (69.9%) used the app for up to 60 minutes. Of them, 65 (30.1%) users used it for >60 minutes with a median time spent of 5 (IQR 2-8) minutes; the median time between initial accession and last use was 39 (IQR 18-60) days. Users accessed one or more modules and followed a nonsequential pattern of use: module 1: 163 (75.4%) users; module 4: 82 (38%); module 5: 67 (31%); module 3: 49 (22.7%); module 2: 41 (19%).

conclusionsThis app, created in an academic setting, is one of a few available in English and Spanish that provides content-vetted HCV education for patients and health care supportive staff. It offers the convenience of on-demand education, allowing users to access crucial information about HCV management and treatment in a self-directed fashion that acknowledges and promotes variable preferences in learning approaches. While app uptake was relatively limited, we propose that future efforts should focus on combined promotion efforts with marketing strategies experts aligned with academic experts. Incorporating ongoing user feedback and integrating personalized reminders and quizzes, will further enhance engagement, supporting the broader public health HCV elimination goals.

Indexed as

Hepatitis CMobile ApplicationsAdultFemaleHealth Knowledge, Attitudes, PracticeHealth PersonnelHumansMaleMiddle AgedPatient Education as TopicSurveys and QuestionnairesUnited StatesawarenesseducationHCVhepatitis C virusHIVinteractive digital interventions (IDI)mobile applicationtestingtrainingtreatmentuser engagement

Identifiers

PMID39486023
PMCPMC11568402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.